Literature DB >> 17159677

Aggressive surveillance and early catheter-directed therapy in the management of intra-abdominal hypertension.

Scott F Reed1, Rebecca C Britt, Jay Collins, Leonard Weireter, Frederic Cole, L D Britt.   

Abstract

INTRODUCTION: Trauma patients represent a heterogeneous group at risk for the development of both primary and secondary abdominal compartment syndrome (ACS). Our study aims at identifying these individuals early in their course and placing an intra-abdominal catheter to reduce intra-abdominal pressure before the serious hemodynamic consequences of ACS occur.
METHODS: During a 10-month period, 12 patients were identified who developed intra-abdominal hypertension. Patients who received 12 L or more of intravenous fluids in the first 24 hours of their resuscitation or received 500 mL/hr of intravenous fluids for more than 4 consecutive hours were considered at risk and had intra-abdominal pressure readings via bladder catheters every 4 hours. After resuscitation, patients were given a physical examination and intra-abdominal pressures were taken every 4 hours or when clinically necessary. When abdominal compartment pressures (ACPs) exceeded 20 mm Hg or the abdominal perfusion pressure (APP = mean arterial pressure-ACP) fell below 50 mm Hg, a diagnostic peritoneal lavage catheter was placed. Fluid volume and type drained, abdominal pressures, heart rate, mean arterial pressure, and pulmonary compliance were recorded. If adequate control of abdominal compartment pressures was not achieved, the patients were managed with a traditional decompressive laparotomy.
RESULTS: Readings taken 30 minutes after placement of the peritoneal catheter showed an average decrease in ACP of 8.0 mm Hg (p = 0.01); an increase in APP of 13.8 mm Hg (p = 0.14); an increase in static pulmonary compliance of 8.1 mL/cmH2O (p = 0.16); and an increase in mean arterial pressure of 5.8 mm Hg (p = 0.52). Ten of the twelve patients were managed nonoperatively. Four patients failed to have their APP improve to >50 mm Hg with the catheter. Two of these patients underwent laparotomy, with one survivor and one mortality secondary to infarcted small bowel. Two did not undergo laparotomy, with one dying of cerebral herniation and the other having care withdrawn. Eight of the twelve patients required intra-abdominal catheters early in their admission (in the first 32 hours), with 7 of 8 surviving. Four patients received intra-abdominal catheters later than day 4 in their admission. All of those four patients died, three within 24 hours. Overall, 5 of the 12 patients died.
CONCLUSIONS: Intra-abdominal catheter placement is a reasonable first step in the early management of ACS. It may prevent a portion of patients from progressing to hemodynamically significant ACS and prevent the complications of managing an open abdominal wound. Also, the late intra-abdominal hypertension may be a prognostic indicator of an impending rapid clinical deterioration. Further prospective investigation is warranted to determine whether this method reduces overall morbidity and mortality in critically ill patients.

Entities:  

Mesh:

Year:  2006        PMID: 17159677     DOI: 10.1097/01.ta.0000245975.68317.5a

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  9 in total

Review 1.  [Influence of volume increase on intra-abdominal pressure].

Authors:  A Schachtrupp
Journal:  Anaesthesist       Date:  2009-05       Impact factor: 1.041

2.  Lessons from Trauma Care: Abdominal Compartment Syndrome and Damage Control Laparotomy in the Patient with Gastrointestinal Disease.

Authors:  Aaron Richman; Clay Cothren Burlew
Journal:  J Gastrointest Surg       Date:  2018-10-01       Impact factor: 3.452

3.  Dalteparin-associated catastrophic retroperitoneal hematoma successfully treated with recombinant factor VIIa.

Authors:  Ching-Hsun Wang; Yeu-Chin Chen; Chih-Wei Tsao; Sung-Sen Yang
Journal:  Int Urol Nephrol       Date:  2011-12-18       Impact factor: 2.370

4.  Normotensive ischemic acute kidney injury as a manifestation of intra-abdominal hypertension.

Authors:  Vijaykumar Lingegowda; A Ahsan Ejaz; Puneet Sood
Journal:  Int Urol Nephrol       Date:  2008-10-25       Impact factor: 2.370

Review 5.  Clinical review: Intra-abdominal hypertension: does it influence the physiology of prone ventilation?

Authors:  Andrew W Kirkpatrick; Paolo Pelosi; Jan J De Waele; Manu Lng Malbrain; Chad G Ball; Maureen O Meade; Henry T Stelfox; Kevin B Laupland
Journal:  Crit Care       Date:  2010-08-27       Impact factor: 9.097

6.  Decompressive laparotomy with temporary abdominal closure versus percutaneous puncture with placement of abdominal catheter in patients with abdominal compartment syndrome during acute pancreatitis: background and design of multicenter, randomised, controlled study.

Authors:  Dejan V Radenkovic; Djordje Bajec; Nenad Ivancevic; Vesna Bumbasirevic; Natasa Milic; Vasilije Jeremic; Pavle Gregoric; Aleksanadar Karamarkovic; Borivoje Karadzic; Darko Mirkovic; Dragoljub Bilanovic; Radoslav Scepanovic; Vladimir Cijan
Journal:  BMC Surg       Date:  2010-07-12       Impact factor: 2.102

7.  Abdominal compartment syndrome - Intra-abdominal hypertension: Defining, diagnosing, and managing.

Authors:  Theodossis S Papavramidis; Athanasios D Marinis; Ioannis Pliakos; Isaak Kesisoglou; Nicki Papavramidou
Journal:  J Emerg Trauma Shock       Date:  2011-04

8.  The respiratory pressure-abdominal volume curve in a porcine model.

Authors:  Adrian Regli; Bart Leon De Keulenaer; Bhajan Singh; Lisen Emma Hockings; Bill Noffsinger; Peter Vernon van Heerden
Journal:  Intensive Care Med Exp       Date:  2017-02-28

Review 9.  Interventional Treatment of Abdominal Compartment Syndrome during Severe Acute Pancreatitis: Current Status and Historical Perspective.

Authors:  Dejan V Radenkovic; Colin D Johnson; Natasa Milic; Pavle Gregoric; Nenad Ivancevic; Mihailo Bezmarevic; Dragoljub Bilanovic; Vladimir Cijan; Andrija Antic; Djordje Bajec
Journal:  Gastroenterol Res Pract       Date:  2015-12-29       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.